2024
Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients. (Journal article)
Belnour, S., Slater, R., Tharmaratnam, K., Karl-Heinz Auth, M., Muhammed, R., Spray, C., . . . Allen, S. (2024). Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients.. United European gastroenterology journal. doi:10.1002/ueg2.12603DOI: 10.1002/ueg2.12603
2021
INVESTIGATION OF THE METABOLOME AND MYCOBIOME IN PARKINSON'S DISEASE (Conference Paper)
Gebeyehu, G. G., Flain, L., Slater, R., Frau, A., Probert, C., Ijaz, U., . . . Warner, T. (2021). INVESTIGATION OF THE METABOLOME AND MYCOBIOME IN PARKINSON'S DISEASE. In GUT Vol. 70 (pp. A18). doi:10.1136/gutjnl-2021-BSG.32DOI: 10.1136/gutjnl-2021-BSG.32
Slater, R., Frau, A., Hodgkinson, J., Archer, D., & Probert, C. (2021). A Comparison of the Colonic Microbiome and Volatile Organic Compound Metabolome of <i>Anoplocephala perfoliata</i> Infected and Non-Infected Horses: A Pilot Study. ANIMALS, 11(3). doi:10.3390/ani11030755DOI: 10.3390/ani11030755
2020
Low FODMAP diet & prebiotic β-galactooligosaccharides improve irritable bowel syndrome and response to low FODMAP is predicted by urine and faecal metabolites: a randomised controlled trial (Journal article)
Wilson, B., Rossi, M., Kanno, T., Hough, R., Probert, C., Parkes, G., . . . Whelan, K. (2020). Low FODMAP diet & prebiotic β-galactooligosaccharides improve irritable bowel syndrome and response to low FODMAP is predicted by urine and faecal metabolites: a randomised controlled trial. PROCEEDINGS OF THE NUTRITION SOCIETY, 79(OCE1), E19. doi:10.1017/S002966511900140XDOI: 10.1017/S002966511900140X
2019
Slater, R. (2019, November 25). Studies of the hindgut and faecal volatile organic compound metabolome and microbiome of the horse.
Papoutsopoulou, S., Burkitt, M. D., Bergey, F., England, H., Hough, R., Schmidt, L., . . . Probert, C. S. (2019). Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients. FRONTIERS IN IMMUNOLOGY, 10. doi:10.3389/fimmu.2019.02168DOI: 10.3389/fimmu.2019.02168
Burkitt, M. D., Williams, J. M., Townsend, T., Hough, R., Duckworth, C. A., & Pritchard, D. M. (2019). Mice lacking NF-κB1 exhibit marked DNA damage responses and more severe gastric pathology in response to intraperitoneal tamoxifen administration (vol 8, e2939, 2017). CELL DEATH & DISEASE, 10. doi:10.1038/s41419-019-1534-0DOI: 10.1038/s41419-019-1534-0
Salem, S. E., Hough, R., Probert, C., Maddox, T. W., Antczak, P., Ketley, J. M., . . . Archer, D. C. (2019). A longitudinal study of the faecal microbiome and metabolome of periparturient mares. PeerJ, 7. doi:10.7717/peerj.6687DOI: 10.7717/peerj.6687
Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice (Journal article)
Reade, S., Williams, J. M., Aggio, R., Duckworth, C. A., Mahalhal, A., Hough, R., . . . Probert, C. S. (2019). Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice. FASEB JOURNAL, 33(3), 3129-3136. doi:10.1096/fj.201800076RRDOI: 10.1096/fj.201800076RR
2018
Hough, R., Archer, D., & Probert, C. (2018). A comparison of sample preparation methods for extracting volatile organic compounds (VOCs) from equine faeces using HS-SPME. METABOLOMICS, 14(02), 10 pages. doi:10.1007/s11306-017-1315-7DOI: 10.1007/s11306-017-1315-7